Share this:
Study: are food and antibiotics linked to irritable bowel syndrome?
Article by Colette Gallagher, Public Affairs
Dr. Purna Kashyap
Is irritable bowel syndrome (IBS) a gut microbiota-related disorder? That is the question Purna Kashyap, M.B.B.S., consultant in gastroenterology, associate director of the Mayo Clinic Center for Individualized Medicine Microbiome Program, and Mayo Clinic researchers wanted to answer as they analyzed studies about gut microbiota and IBS.
The study, published in the American Journal of Physiology—Gastrointestinal and Liver Physiology helps connect the dots between gut microbiota and development of IBS.
According to the authors, the outlook is optimistic, and they now have the necessary tools and the knowledge as they embark on developing effective microbiota targeted therapies for IBS.
Learn more about the role of the microbiome in health and disease
- Mayo Clinic Center for Individualized Medicine Microbiome Program
- Vaginal microbes point toward early detection and screening for endometrial cancer
- Probiotics and diet: learning the facts about gut health
- This diet’s for you: personalized nutrition to improve your health
- Microbiome: All You Need is Bugs
Learn more about precision medicine and join our community
Get the latest news from the Center for Individualized Medicine. Visit our blog, Facebook, LinkedIn or Twitter at @MayoClinicCIM.
Save the date for the next Individualizing Medicine Conference on Oct. 9-11, 2017.
Tags: center for individualized medicine, Dr. Purna Kashyap, gut bacteria, IBS, irritable bowel syndrome, mayo clinic, medical research, microbiome, microbiota, Uncategorized